Keith Regnante

KROS

Keith Regnante serves as officer: CHIEF FINANCIAL OFFICER at Keros Therapeutics, Inc. (KROS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$155.0K

Net Position

Net Seller

$155.0K

Companies Traded

KROS

Active Period

Feb 2026

2 total trades

Most Recent

Sell KROS

Feb 20, 2026 · $77.5K

Keith Regnante's Insider Trading at Keros Therapeutics, Inc. (KROS)

Buys

0 · $0.00

Sells

2 · $155.0K

Total Shares Bought

Total Shares Sold

9,478

KROS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 20, 2026↗	Sell	4,739	$16.35	$77.5K	39,261
Feb 18, 2026↗	Sell	4,739	$16.35	$77.5K	0

Related Insiders

BIENAIME JEAN JACQUES

director

KROSBuy · Mar 9, 2026

Jasbir Seehra

CHIEF EXECUTIVE OFFICER

KROSSell · Feb 19, 2026

Jasbir Seehra

director, officer: CHIEF EXECUTIVE OFFICER

KROSSell · Feb 19, 2026

Lorena Raquel Lerner

officer: Chief Science Officer

KROSSell · Feb 18, 2026

Lorena Raquel Lerner

Chief Science Officer

KROSSell · Feb 18, 2026

Esther Cho

officer: SVP, General Counsel

KROSSell · Feb 18, 2026

Esther Cho

SVP, General Counsel

KROSSell · Feb 18, 2026

Explore More Insider Trading Data

KROS Insider Trading Activity

View all insider trades at Keros Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity